Astragaloside IV attenuates hypoxia-induced cardiomyocyte damage in rats by upregulating superoxide dismutase-1 levels

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 4, 2009, Pages 351-357

  Hu, Jiong Yu ^a   Han, Jian ^b   Chu, Zhi Gang ^a   Song, Hua Pei ^a   Zhang, Dong Xia ^a   Zhang, Qiong ^a   Huang, Yue Sheng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Astragaloside IV; Cardiac; Free radical; Hypoxia; Superoxide dismutase

Indexed keywords

ASTRAGALOSIDE IV; COPPER ZINC SUPEROXIDE DISMUTASE; DIETHYLDITHIOCARBAMIC ACID; FLUORESCEIN ISOTHIOCYANATE; MALONALDEHYDE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL HYPOXIA; CELL PROTECTION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; GENE EXPRESSION; HEART MUSCLE CELL; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SAPONINS; SUPEROXIDE DISMUTASE; TRITERPENES; UP-REGULATION;

EID: 68849105275     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.05059.x     Document Type: Article

References (34)

1. Horwitz LD, Fennessey PV, Shikes RH, Kong Y. Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion. Circulation 1994 89 : 1792 801.
2. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990 336 : 261 4.
3. Kyriakides ZS, Kremastinos DT, Michelakakis NA, Matsakas EP, Demovelis T, Toutouzas PK. Coronary collateral circulation in coronary artery disease and systemic hypertension. Am. J. Cardiol. 1991 67 : 687 90.
4. Yang JM, Yang ZC. The relationship between myocardial nutrition flow and myocardial damage after sever burn in rat. Zhong Guo Wei Xun Huan 1998 3 : 142 7 (in Chinese).
5. Huang YS, Zhang JP, Li XH. Serial studies on postburn shock heart. Burns 2007 33 : S14 15.
6. Huang YS. Progression on the molecular mechanism and management of early myocardial injury after severe burns. Zhonghua Shaoshang Zazhi 2006 22 : 161 7 (in Chinese).
7. Zweier JL. Measurement of superoxide-derived free radicals in the reperfused heart: Evidence for a free radical mechanism of reperfusion injury. J. Biol. Chem. 1988 263 : 1353 7.
8. Prabhakar NR, Kumar GK. Oxidative stress in the systemic and celluar response to intermittent hypoxia. Biol. Chem. 2004 385 : 217 21.
9. Shao ZH, Li CQ, Terry LV et al. Extract from Scutellaria baicalensis Georgi attenuates oxidant stress in cardiomyocytes. J. Mol. Cell. Cardiol. 1999 31 : 1885 95.
10. Negoro S, Kunisada K, Fujio Y et al. Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation- induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation 2001 104 : 979 81.
11. Shao ZH, Terry LV, Yimin Qin et al. Baicalein attenuates oxidant stress in cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2002 282 : H099 1006.
12. Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. Reactive oxygen species, cell signaling, and cell injury. Free Radic. Biol. Med. 2000 28 : 1456 62.
13. Gao Z, Huang K, Xu H. Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells. Pharmacol. Res. 2001 43 : 173 8.
14. Yang HJ, Chen XC, Zheng M, Zhang D, Tan L, Cheng SM. Studies on the free radical scavenging ability of Astragalus membranaceus and Salvia miltiorrhiza. J. Fudan Univ. Nat. Sci. 2003 6 : 935 8 (in Chinese).
15. Ma XQ, Shi Q, Duan JA, Tina TX, Karl WK. Chemical analysis of Radix astragali (Huangqi) in China: A comparison with its adulterants and seasonal variations. J. Agric. Food Chem. 2002 50 : 4861 6.
16. State Pharmacopoeia Commission of the PRC. Pharmacopoeia of the People's Republic of China: V. 1. People's Medical Publishing House, Beijing, 2005.
17. Tohda C, Tamura T, Matsuyama S, Komatsu K. Promotion of axonal maturation and prevention of memory loss in mice by extracts of Astragalus mongholicus. Br. J. Pharmacol. 2006 149 : 532 41.
18. Zhang YY, Zhu HY, Huang CG et al. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma. J. Cardiovasc. Pharmacol. 2006 47 : 190 5.
19. Zhang WJ, Hufnagl P, Binder BR, Wojta J. Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression. Thromb. Haemost. 2003 90 : 904 14.
20. Zhang WD, Chen H, Zhang C, Liu RH, Li HL, Chen HZ. Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro. Planta Med. 2006 72 : 4 8.
21. Wang YP, Li XY, Song CQ, Hu ZB. Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice. Acta Pharmacol. Sin. 2002 23 : 263 76.
22. Zhang WD, Zhang C, Wang XH et al. Astragaloside IV dilates aortic vessels from normal and spontaneously hypertensive rats through endothelium-dependent and endothelium-independent ways. Planta Med. 2006 72 : 621 6.
23. Yu QC, Zhu TY, Zhang YK. Effect of astragaloside IV on the long-term consequences of renal ischemia-reperfusion injury in rat. Zhonghua Yi Xue Za Zhi 2004 84 : 1412 15 (in Chinese).
24. Luo Y, Qin Z, Hong Z, Zhang XD, Fu JH. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Neurosci. Lett. 2004 363 : 218 23.
25. Chlopcíková S, Psotová J, Miketová P. Neonatal rat cardiomyocytes: A model for the study of morphological, biochemical and electrophysiological characteristics of the heart. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 2001 145 : 49 55.
26. Seko Y, Takahashi M, Tobe K, Kadowaki T, Yazaki Y. Hypoxia and hypoxia/reoxygenation activate p65 (PAK), p38mitogen-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK) in cultured rat cardiac myocytes. Biochem. Biophys. Res. Commun. 1997 239 : 840 4.
27. Takeuchi A, Mishina Y, Miyaishi O, Kojima E, Hasegawa T, Isobe K. Heterozygosity with respect to zfp148 causes complete loss of fetal germ cells during mouse embryogenesis. Nat. Genet. 2003 33 : 172 6.
28. Umezu-Goto M, Kishi Y, Taira A et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 2002 158 : 227 33.
29. Lee S, Kuo W, Lin J et al. Effects of long-term intermittent hypoxia on mitochondrial and Fas death receptor dependent apoptotic pathways in rat hearts. Int. J. Cardiol. 2007 116 : 348 56.
30. -. Zhong Yao Cai 1999 22 : 303 6 (in Chinese).
31. Zhang WD, Zhang C, Liu RH et al. Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs. Life Sci. 2006 79 : 808 15.
32. Huang CB, Ci YX, Chang WB. The chemoluminescence response of FITC-BSA marker. Anal. Chem. 2002 30 : 447 9.
33. 2α expression by N,N-diethyldithiocarbamate in PC12 cells: Involvement of reactive oxygen species and nitric oxide. Toxicol. Appl. Pharmacol. 2006 215 : 218 27.
34. Luo JZ, Xuan YT, Gu Y, Prabhu SD. Prolonged oxidative stress inverts the cardiac force-frequency relation: Role of altered calcium handling and myofilament calcium responsiveness. J. Mol. Cell. Cardiol. 2006 40 : 64 75.